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Abstract 
Background: Hypertensive disorders of pregnancy (HDP) account for nearly 18% of all maternal deaths 
worldwide. Preeclampsia is a leading cause of direct maternal mortality worldwide, and the second in Uganda 
contributing about 9.1% of total maternal death. Expectant management of severe pre-eclampsia at 30–34 weeks 
is associated with good perinatal outcome and risk reduction for the mother. Methods: This was a retrospective 
cohort study done by reviewing maternal medical records from September 2009 to September 2011 and all 
mothers who had delivered at Mbarara Hospital with a diagnosis of severe pre-eclampsia (SPE) during study 
period were included in the study.  Results: Primigravidae accounted for about 42.6% of the cases of severe pre-
eclampsia studied and majority (66.7%) of the women were aged between 20-30 years. The overall good fetal 
outcome rate in this study was 47.5% and 68.3% of the women studied were more than 28 weeks of 
amenorrhoea and 31.2% had still births. The most common symptom was headache (47%) and over 35% of 
these women presented for delivery more than 72hours from onset of symptoms. Delivery between 0-18 hours 
was protective, (OR0.43, 95%CI : 0.29-0.5), p-value=0.013). Conclusions: The complication rate associated 
with severe preeclampsia is high and worsens with longer duration of symptoms before delivery. Delivery within 
18 hours of onset of symptoms is associated with good fetal outcomes and this stresses the importance of early 
presentation for care by the mothers and timely decision making by the clinicians.  
 
INTRODUCTION 
Hypertensive disorders of pregnancy (HDP) account for nearly 18% of all maternal deaths worldwide, with an 
estimated 62,000–77,000 deaths per year. The incidence of hypertensive disorders in pregnancy in a survey by 
WHO was found to be 2.73% with pre-eclampsia accounting for the bulk of these cases. However, data on the 
incidence of HDP are scarce, as shown in a recently published systematic review, ⁴ where just 74 studies from 
40 countries reported the incidence of pre-eclampsia and eclampsia, only seven of these with data on national 
coverage. Preeclampsia is a leading cause of direct maternal mortality worldwide, and the second in Uganda 
contributing about 9.1% of total maternal death, only after haemorrhage and sepsis Maternal near-miss cases are 
eight times more frequent in women with pre-eclampsia, and increased to up to 60 times more frequent in 
women with eclampsia, when compared with women without these conditions¹’². Preeclampsia and eclampsia 
are major causes of fetal mortality and morbidity⁹. 
HDP fall into four categories: chronic (pre-existing) hypertension, gestational hypertension or 
pregnancy-induced hypertension (PIH), pre-eclampsia / eclampsia and pre-eclampsia superimposed on chronic 
hypertension³. For every woman who dies, it is estimated that 20 others suffer severe morbidity or disability⁵. 
The proportion of women surviving severe maternal complications (also called ‘near-miss’ cases) has been 
proposed as a useful gauge for the evaluation of the quality of maternal health care and its determinants, with the 
potential to complement the information obtained from the reviews of maternal deaths⁶,⁷.  
The risk factors associated with a greater risk of severe preeclampsia and, or eclampsia include personal 
history of preeclampsia, personal history of pre-existing hypertension, primi-parity, and fewer than four 
antenatal care visits⁸. Expectant management of severe pre-eclampsia at 30–34 weeks is associated with good 
perinatal outcome and risk reduction for the mother¹⁰. 
In areas where careful intensive monitoring of the mother is possible these complications are relatively 
rare. Data are not sufficient to decide whether it is better to intervene or to apply a policy of expectant care for 
women with early onset of severe pre-eclampsia. Lack of human and material resources to monitor women 
intensively for a prolonged period may render expectant management difficult to implement in resource-poor 
settings. Expectant management of SPE in gestation age between 18-27 weeks was associated with perinatal 
mortality 87%, no mothers died, placental abruption, eclampsia, consumptive coagulopathy, renal failure, 
intracerebral haemorrhage, ruptured hepatic hematoma. SPE in gestation age between 28-32 week was 
associated with prolonged mean of 15.4 days of gestation sustained 4% placental abruption (Sibai et al, 1994).  
Insufficient data for reliable conclusions on maternal and fetal outcome and there is need for in-depth 
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research on this topic (The Cochrane Database of Systematic Reviews 2002). 
This study therefore aimed at determining the effect of time duration from onset of symptoms to delivery on 
maternal and perinatal outcomes of mothers at Mbarara Regional Referral Hospital (MRRH) and will therefore 
contribute towards evidence based recommendations on management protocols of severe preeclampsia in 
resource limited settings.  
 
METHODS AND MATERIALS: 
Study site: The study was conducted on maternity ward at Mbarara Regional Referral Hospital. The hospital is a 
265 bed capacity and is government owned and funded through the ministry of Health and it doubles as a 
teaching hospital for Mbarara University faculty of medicine and regional referral hospital for south western 
Uganda. There is a neonatal intensive care unit on paediatrics ward and a busy maternity ward with labour suite, 
antenatal, postnatal wards and operating theatres. The hospital delivers about 10,000 mothers annually.  
Study design: Retrospective cohort study was done by reviewing maternal medical records from September 
2009 to September 2011.  
Study population: All mothers who had delivered at MRRH from September 2009 to September 2011 with a 
diagnosis of severe pre-eclampsia (SPE) during study period were included in the study.  
Outcome variables included the following: 
Maternal outcomes: Abruptio placenta, HELLP syndrome, loss of blood pressure control, severe renal 
impairment, eclampsia, admission to intensive care unit, pulmonary oedema and cerebrovascular incident, 
disseminated intravascular coagulopathy (DIC), intracerebral haemorrhage, ruptured hepatic hematoma, 
caesarean delivery, need for transfusion of blood products, and death. 
Fetal outcomes: Prematurity and its complications (including Respiratory Distress Syndrome, necrotising 
enterocolitis, LBW), intra uterine growth restriction, chronic fetal distress, intra uterine fetal death, early 
neonatal death. 
Exposure variables: Maternal age, parity, previous preeclampsia, chronic hypertension, gestational age at 
diagnosis, blood platelet count and peak serum levels of aspartate aminotransferase, creatinine, uric acid and 
lactate dehydrogenase. 
Sampling method and sample size calculation: Consecutive case sampling was done and a total of 105 cases 
were calculated using the Fleiss formula. 
Data collection: Review of case records was done for those that met the criteria and target parameters were 
recorded on the data collection tool including patient demographics, signs and symptoms of PET severity and 
their duration, interventions, time interval between onset of symptoms and  delivery,  maternal and foetal 
outcomes and factors associated with the outcome. Good outcome was considered as a live mother without 
complications and a live baby without complications whether term or premature while a poor outcome was a 
maternal death or a live mother with complications and stillbirth or live baby with low Apgar score. 
Statistical analysis plan: The data was entered in an EXCEL spreadsheet and analysed using SPSS statistical 
software, version 20 (SPSS, Chicago, IL, USA). Cross tabulations was conducted to obtain descriptive statistics 
which were presented as frequencies, percentages and Pearson Chi-square statistics. Bivariable and multivariable 
logistic regression models were used to test the association of the independent variables with the dependent 
(outcome) variable. Variables with p-value <0.05 at bivariable analysis were included in multivariable logistic 
regression analysis. Results were presented with odds ratios and the corresponding 95% Confidence Intervals 
and significance was accepted at p < 0.05. 
Quality assessment of the data: The completed data abstraction forms were checked by the principle 
investigator for missing data or discrepancies. An independent Obstetrician, not part of the research team would 
check every tenth form. All data were double entered and cross-checked in EXCEL spreadsheet. The study tool 
was pre-tested before commencement of the research process. Research assistants were trained on the use of the 
questionnaires 
Ethical approval: Ethical approval to carry out the study was obtained from Mbarara University of Science and 
Technology research ethics committee (MUST REC) and the Uganda National Council for Science and 
Technology (UNCST). Permission to carry out the research was sought from the administration of MRRH.  
Limitations: Inability to get complete information due to incomplete recording and loss to follow up, detailed 
information could not be obtained by this method.  
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RESULTS 
Table 1: Participants characteristics  
Variable  Frequency, n (%)  
Age(years)   
<20 
20-30 
>30 
 
14 (13.9) 
67 (66.3) 
20 (19.8) 
Gravidity  
Prime gravida 
Multigravida 
 
43 (42.6) 
53 (57.4) 
Magnesium sulphate 
             Yes 
             No            
 
82 (81.2) 
14 (13.9) 
Induction  
             Yes 
             No 
 
37 (36.6) 
56 (55.4) 
Distance from the health unit (km) 
>5 
<5 
 
62 (61.4) 
39 (38.6) 
Gestation age(weeks) 
<20 
20-27 
28-36 
>36 
 
1 (1) 
11 (10.9) 
37 (36.6) 
32 (31.7) 
Mean systolic BP(mmHg) 
<160 
≥160 
 
11 (10.9) 
90 (89.1) 
Mean diastolic BP(mmHg) 
<110 
≥110 
 
33 (32.7) 
68 (67.3) 
Mode of delivery 
Vaginal 
C/S 
 
43 (42.6) 
49 (48.5) 
Mean time lag between onset of symptoms and delivery 
0-6 hours 
7-12 hours 
13-24 hours 
25-48 hours 
49-72 hours 
73 hours-7 days 
8-14 days 
15-21 days 
>21 days 
Missing  
 
4 (4) 
1 (1) 
18 (17.8) 
2 (2) 
10 (9.9) 
17 (16.8) 
6 (5.9) 
5 (5) 
8 (7.9) 
30 (29.7) 
Number of foetuses 
Single 
Twins  
 
88 (87.1) 
6 (5.9) 
Status of baby before birth 
Well 
Distressed 
IUFD 
 
65 (64.4) 
10 (9.9) 
12 (11.9) 
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Table 2: Pregnancy outcome of mothers with severe Pre-eclampsia at Mbarara Regional Referral Hospital 
Maternal Outcome Fetal Outcome   
 N=92  N=93 
HELLP syndrome 4 (4.3) Normal 43 (46.2) 
DIC 1 (1.1) Birth asphyxia 7 (7.5) 
Convulsions 26 (28.3) ENND 1 (1.1) 
Oliguria 2 (2.2) FSB 13 (14.0) 
IUFD 1 (1.1) MSB 15 (16.1) 
Mental confusion 1 (1.1) Live premature 12 (12.9) 
None  57 (62.0) Abortion 1 (1.1) 
- 
- 
- 
- 
- 
- 
- 
- 
Birth weight (kg) 
<1 
1.1-1.5 
1.6-2.0 
2.1-2.5 
>2.5 
Missing  
 
2 (2) 
8 (7.9) 
13 (12.9) 
14 (13.9) 
29 (28.5) 
35 (34.7) 
Overall maternal outcome 
Good  
Poor 
Missing  
 
76 (75.2) 
17 (16.8) 
08 (7.9) 
Overall fetal outcome  
Good  
Poor  
Missing  
 
48 (47.5) 
45 (44.8) 
08 (7.9) 
 
Table 3: Factors associated with maternal outcomes 
  Maternal n=88  
Variable  Categories  Bad 
outcome 
Good outcome P-value  
 Age     
<20 
20-30 
31-40 
 
5 
10 
2 
 
9 
51 
16 
0.2 
Gravidity PG    
Multigravida 
8 
8 
33 
39 
0.8 
Gestation age at delivery in 
weeks 
 
< 20 
20-27 
28-36 
> 36 
 
1 
2 
8 
3 
 
0 
8 
26 
26 
0.1 
Highest systolic BP  
<140 
140-150 
151-160 
161-170 
171-180 
181-190 
191-200 
>200 
 
0 
3 
2 
1 
1 
2 
3 
5 
 
1 
5 
11 
7 
12 
15 
9 
16 
0.7 
Highest diastolic BP  
<100 
100-110 
111-120 
121-130 
131-140 
>140 
 
2 
5 
2 
1 
5 
2 
 
7 
33 
16 
7 
8 
5 
0.3 
Urine protein  
Plus 1 
Plus 2 
Plus 3 
Plus 
 
0 
1 
6 
3 
 
3 
1 
20 
23 
0.5 
Induction of labour  
 
 
Yes 
No 
 
10 
6 
 
26 
47 
0.05 
Journal of Health, Medicine and Nursingwww.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.26, 2016 
 
5 
 
Table 4: Factors associated with foetal outcomes in severe pre-eclampsia   
  Foetal 
n=88 
 
Variable  Bad 
outcome 
Good outcome P-value  
 Age    
 
 
 
<20 
20-30 
31-40 
 
7 
28 
10 
 
7 
33 
8 
0.8 
Gravidity 
 
 
Prime gravida 
Multigravida 
 
18 
24 
 
23 
23 
0.5 
Gestational age, wks  
< 20 
20-27 
28-36 
> 36 
 
1 
10 
19 
7 
 
0 
0 
15 
22 
0.000 
Highest diastolic BP mmhg <100 
100-110 
111-120 
121-130 
131-140 
>140 
3 
16 
11 
3 
9 
3 
6 
22 
7 
5 
4 
4 
0.4 
Urine protein  
<999 
Plus 1 
Plus 2 
Plus 3 
Plus 4 
 
0 
2 
2 
14 
14 
 
1 
1 
0 
12 
12 
0.5 
Induction of labour  
 
Yes 
No 
25 
18 
11 
35 
0.001 
Mode of delivery Svd  
C/S 
10 
6 
33 
43 
 
0.2 
 
Table 5: Time intervals versus fetal outcomes 
Time(hours)  Feotal outcome Odds ratio p-Value 
 Poor Good    
>6 
0-6 
38 
0 
29 
4 
0.43 (0.33-0.57) 0.027 
>12 
0-12 
38 
0 
28 
5 
0.42 (0.32-0.56) 0.013 
>18 
0-18 
38 
0 
28 
5 
0.42 (0.32-0.56) 0.013 
>24 
0-24 
28 
10 
21 
12 
1.60 (0.58-4.40) 0.361 
>30 
0-30 
28 
10 
20 
13 
1.82 (0.67-4.97) 0.240 
>48 
0-48 
26 
12 
20 
13 
1.41 (0.53-3.47) 0.482 
>60 
0-60 
26 
12 
19 
14 
1.60 (0.60-4.32) 0.344 
>72 
0-72 
19 
19 
16 
17 
1.06 (0.42-2.70) 0.817 
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DISCUSSION OF RESULTS 
Primigravida accounted for about 42.6% of the cases of severe pre-eclampsia studied and majority (66.7%) of 
the women were aged between 20-30 years. This compares well with a study by Parveen M et al in 2015 in south 
India where 46.23% of the women studied were primigravida and were about 70% of them were aged between 
21 and 30 years¹¹. This is probably because the two studies were done in similar settings-tertiary or referral 
hospitals and had similar patient characteristics. 
The overall good fetal outcome rate in this study was 47.5% which is lower compared to the study by 
Parveen M et al in 2015 where the good fetal outcome rate was 62.3%.¹¹ It is possible that the population in 
south East India presented earlier than the ones in our study. 
Of the women studied, 68.3% were more than 28 weeks of amenorrhoea and 31.2% had still births. 
There is evidence by L.L Simpson 2002 that suggests that beginning at approximately 36 weeks, the risk of 
intrauterine fetal demise increases substantially and severe preeclampsia represents significant risk factor for 
intrauterine fetal demise, with estimated stillbirth rate of 21 per 1000.¹²’¹³ 
The most common symptom was headache (47%) and over 35% of these women presented for delivery 
more than 72hours from onset of symptoms. In a study by Al-Safi Z et al 2005 where about 90% of patients 
studied presented within 7 days after discharge from the hospital and the most common presenting symptom was 
headache in 105 (69.1%) of patients.¹⁴ In both studies, the commonest symptom was headache. Prematurity 
being the commonest fetal complication 
Delivery between 0-18 hours was protective OR 0.43, CI=0.29-0.52), p-value 0.013. Delivery after 
36weeks gestation was protective to fetus while delivery by C/S was associated with good maternal and fetal 
outcome p value 0.000 while induction of labour was associated with poor outcome OR 4.4, CI: 1.78-10.9. 
Visual blurring and headache were associated with poor outcome mainly headache and blurring of vision. P 
value 0.009 
Conclusions and recommendations: 
The complication rate associated with severe preeclampsia is high and worsens with longer duration of 
symptoms before delivery. Delivery within 18 hours of onset of symptoms is associated with good feotal 
outcomes and this stresses the importance of early presentation for care by the mothers and timely decision 
making by the clinicians. Survival for babies after 18 hours from onset of symptoms is by chance. Delivery by 
C/S is protective to both mothers and babies. There is need to enhance health education to mothers about 
symptoms of severe pre-eclampsia during antenatal care so that they can present early for care.  
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